“양주건마🍜 ┘OPDAL050.COM└오피달리기 🚔양주오피😅양주오피💗양주스웨디시🌾양주스웨디시💣양주아로마🌃양주OP♋️”的搜索结果，显示 81-90 项，共有 11888 项

1. 放射科- 临床试验- 妙佑医疗国际

   The purpose of this study is to retrospectively review the imaging findings of the uterine leiomyosarcoma and compare with those of atypical leiomyoma. Clinical ...

2. 血液科- 临床试验- 妙佑医疗国际

   ... cancer and small cell lung cancer. Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and ...

3. 保留乳头乳房切除术- 妙佑医疗国际

   For early-stage breast cancer that is not close to the nipple or does not involve the nipple itself, nipple-sparing mastectomy can be an effective way to treat ...

4. 放射科- 临床试验- 妙佑医疗国际

   Rochester, Minn. VERIFY will validate biomarkers of upper extremity (UE) motor outcome in the acute ischemic stroke window for immediate use in clinical trials, ...

5. 外科 - 临床试验- 妙佑医疗国际

   Levels of bladder cancer-derived extracellular vesicles become undetectable after radical cystectomy in patients with localized bladder cancer. This study hopes ...

6. 血液科- 临床试验- 妙佑医疗国际

   ... cancer and small cell lung cancer. Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and ...

7. 血液科- 临床试验- 妙佑医疗国际

   ... cancer called multiple myeloma. Linvoseltamab has previously been studied as a single agent (without other cancer treatments) in participants with multiple ...

8. 血液科- 临床试验- 妙佑医疗国际

   ... cancer and small cell lung cancer. Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and ...

9. 血液科- 临床试验- 妙佑医疗国际

   :Cohort 1 includes (1) advanced unresectable pancreatic cancer, (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype: triple negative ...

10. 放射科- 临床试验- 妙佑医疗国际

    The overall goal of this project is to study a new 3D ultrasound imaging technology for evaluation of axillary lymph nodes in patients with breast cancer.